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A 72-year-old man presented with a 1-month history of cough,

ceftriaxone and azithromycin for suspected pneumonia. Thoracentesis

shortness of breath, weight loss, and fatigue. Ten months earlier he

demonstrated exudative pleural effusion and Staphylococcus haemo-

underwent bilateral lung transplantation (cytomegalovirus [CMV]

lyticus was isolated on fluid culture. The serum Aspergillus galactoman-

donor negative/recipient positive, Epstein–Barr virus [EBV] recipi-

nan was elevated at 2.56 index. The fatigue, weight loss, and positive

ent positive) for idiopathic pulmonary fibrosis, with basiliximab and

EBV serology was concerning for concomitant lung malignancy or

methylprednisolone induction followed by tacrolimus and pred-

posttransplant lymphoproliferative disorder (PTLD), and a bronchos-

nisone maintenance. Early posttransplantation course was com-

copy and transbronchial biopsy was performed. No evidence of ma-

plicated by bilateral anastomosis stenosis with pseudomembrane

lignancy was found on pathology. The macroscopic and microscopic

formation and Pseudomonas aeruginosa pneumonia. Posttransplant,

appearance of the pathogen isolated from bronchoalveolar lavage is

he did not require treatment for transplant rejection. The patient

shown in Figures 2 and 3. The patient underwent additional treatment.

received antifungal prophylaxis with inhaled liposomal amphotericin-B and CMV prophylaxis with valganciclovir for the first 3 months
after transplantation. At the time of hospitalization, he was receiving
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trimethoprim-sulfamethoxazole for prophylaxis and azithromycin
for prevention of bronchiolitis obliterans syndrome.
On examination, he was afebrile. Breath sounds were diminished

1. The clinical presentation and lung nodules seen in Figure 1 is
most consistent with:

in the right base. He had a normal white blood cell count of 8.3 × 103/

a. A community-acquired bacterial pneumonia

μl and an elevated C-reactive protein of 2.8 mg/dl. Contrast tomogra-

b. A respiratory viral infection

phy (CT) of the chest revealed right pleural effusion and nodular opac-

c. An opportunistic mold infection

ities in the right and left lower lobes (Figure 1). He was initiated on

d. Pulmonary toxicity due to medication
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(B) contrast tomography of the chest
demonstrating scattered bilateral nodular
and consolidative opacities
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2. Which of the following is an independent risk factor for invasive
mold infections after lung transplantation?
a. Double lung transplant
b. Epstein–Barr virus infection
c. Augmented immunosuppression for rejection
d. Bronchiolitis obliterans
3. The patient’s serum Aspergillus galactomannan antigen was positive. Which of the following may cause a false-positive galactomannan test?
a. Use of antifungal prophylaxis
b. Infection with a non-Aspergillus mold
c. Crossreactivity with cephalosporin antibiotics
d. Respiratory colonization with Candida sp.
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4. Based on the microbiology shown in Figures 2 and 3, what is the
appropriate initial treatment?
a. Voriconazole
b. Flucytosine
c. Amphotericin B
d. Trimethoprim-sulfamethoxazole
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microscopic features of the pathogen (400× magnification)
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